Breast implants are a major health hazard.  Don’t do it. They will make your life miserable, and they might send you to the other side. Breast implant sizes are measured by volume using cubic centimeters (cc’s). A larger implant means more volume and further projection from the chest wall. When deciding what breast size to choose, bear in mind that every woman’s body type is different and this affects how the implants will look. Therefore, two women may have the same sized implants, but each procedure will yield a different result.

Before getting the procedure done, you will need to first decide: How big do you want your breasts to be? How perky would you like them to look? What shape would you like them to have? Where on your chest would you like them to sit? How would you like your cleavage to appear and where do you desire for your scar to be? 

The plastic surgical emplacement of breast implant devices, either for breast reconstruction or for aesthetic purpose, presents the same health risks common to surgery, such as adverse reaction to anesthesia, hematoma (post-operative bleeding), late hematoma (post-operative bleeding after 6 months or more), seroma (fluid accumulation), incision-site breakdown (wound infection). Complications specific to breast augmentation include breast pain, altered sensation, impeded breast-feeding function, visible wrinkling, asymmetry, thinning of the breast tissue, and symmastia, the “bread loafing” of the bust that interrupts the natural plane between the breasts. Specific treatments for the complications of indwelling breast implants—capsular contracture and capsular rupture—are periodic MRI monitoring and physical examinations. Furthermore, complications and re-operations related to the implantation surgery, and to tissue expanders (implant place-holders during surgery) can cause unfavorable scarring in approximately 6–7 per cent of the patients. Statistically, 20 per cent of women who underwent cosmetic implantation, and 50 per cent of women who underwent breast reconstruction implantation, required their explantation at the 10-year mark.

Many women with breast implants have reported connective tissue diseases such as systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis, and fibromyalgia. Various other systemic symptoms have been evidenced at large and fall under the term Breast Implant Illness. Symptoms include extreme fatigue, cognitive dysfunction (brain fog, memory loss, difficulty concentrating), joint and muscle pain, dryness throughout the body, hair loss, tingling and numbness in the extremities, recurring infections, endocrine problems (thyroid, adrenals, etc.), and more.

Platinum is used in the production of silicone gel for breast implants and small amounts may leach into surrounding tissues. Ernest Lykissa and Susan Maharaj did research on silicone breast implants and platinum. In their Analytical Chemistry paper, which is a top journal of the field, they reported finding the highest platinum to date in women who had implants. They also found that the platinum is transformed into an oxidized state which is more harmful.

The FDA has identified that breast implants may cause a rare form of cancer called anaplastic large-cell lymphoma, notably when the implants are textured. As of February 1, 2017, the FDA has received a total of 359 medical device reports of breast-implant-associated ALCL, including 9 deaths. If women have swelling or fluid collection, a CD30 test must be done. The American Society of Plastic Surgery (ASPS) states, “CD30 is the main diagnostic test that must be performed on the seroma fluid as routine pathology or H&E staining can frequently miss the diagnosis.” Diagnosis and treatment of breast implant associated ALCL now follows standardized guidelines established by the National Comprehensive Cancer Network.

“The current lifetime risk of BIA-ALCL in the U.S. is estimated to be 1:30,000 women with textured implants based upon current confirmed cases and textured implant sales data over the past two decades. This is consistent with risk reported in Europe. Certain geographic locations have demonstrated variable risks. For instance, a December 2016 update from the Therapeutic Goods Administration of Australia and New Zealand reported a risk of 1:1,000 to 1:10,000 for textured implants.”

The ASPS and the Plastic Surgery Foundation (PSF) have partnered with the FDA to study this condition and in doing so created the Patient Registry and Outcomes For breast Implants and anaplastic large cell Lymphoma Etiology and epidemiology (PROFILE). The United States FDA strongly encourages all physicians to report cases to PROFILE in an effort to better understand the role of breast implants in ALCL and the management of this disease.



By Basil Venitis

View that stirs up any man
Split of chest with great lumen
Milky breasts that comfort humans
Cleavage of well-endowed woman.

Want to kiss that great spot
Touch and feel of being human
Lick my joy’s habitat
Cleavage of well-endowed woman.

Have to suck that milky gorge
Have to milk that gorgeous woman
Only God can really forge
Cleavage of well-endowed woman.

Breastfeed now a big boy
Help him grow super human
Give him biggish booby joy
Cleavage of well-endowed woman.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s